Excellere Partners completes sale of U.S. Water Services to Allete

NewsGuard 100/100 Score

Excellere Partners, a Denver-based private equity firm focused on partnering with middle-market entrepreneurs and management teams, announced today that it completed the sale of its portfolio company U.S. Water Services, Inc. (U.S. Water), to Allete (NYSE: ALE) on February 10, 2015. Headquartered in St. Michael, Minnesota, U.S. Water is an innovative provider of integrated industrial solutions for water treatment.

Excellere's investment success in U.S. Water continues to demonstrate the Firm's hands-on, disciplined value creation process that focuses on foundation building, process improvement and strategic growth initiatives to build best-in-class companies in attractive industry segments. The execution of these strategic initiatives provided U.S. Water with the support to grow from an upper-Midwest regionally-focused provider of industrial water treatment services, to an industry leader with production facilities and representation nationwide. Following Excellere's four year investment period the Company now serves a growing and diverse mix of over 3,600 customers, including a significant number of Fortune 500 companies. U.S. Water is known for providing integrated water management solutions combining chemicals, equipment and engineering services that offer clients customized solutions to optimize system efficiency and reliability.

Excellere's exit of U.S. Water is a continuation of the tremendous momentum the Firm is currently experiencing. According to Managing Partner David Kessenich, "The momentum started in July with an investment in DentMall, a Miami-based dental practice management company, and continued with three highly-successful exits, two additional platform investments, and one strategic add-on. The pace of activity continues into 2015 with a strong pipeline of new investment opportunities."

In the midst of what many private equity insiders consider to be a challenging market, driven by excessive competition for quality companies and valuations at historical highs, Excellere has been able to achieve its most active period in the Firm's history. Kessenich went on to say, "It may seem like an over-simplification, but it's a combination of a lot of hard work, a sound long-term investment strategy, a proprietary value creation model that is highly attractive to entrepreneurs and some good fortune. In looking back over the last half of 2014, it really is a culmination of all the efforts we've put into our industry-focused investment thesis and the value creation programs that we implement with our management teams."

In addition to the July DentMall investment that started this run for Excellere, in December the firm made investments in TrialCard Inc., a Raleigh, NC-based provider of patient access and medication adherence support services to the pharmaceutical industry, and completed the acquisition of a geospatial information software and services provider for Systems Integrity Management Solutions (SIMS), a Houston-based provider of asset integrity solutions to midstream and downstream energy companies. Excellere's most recent investment occurred in January, with the recapitalization of a neuro-rehabilitation company that provides high-level, post-acute rehabilitation to persons who have sustained an acquired brain injury.

Exits have equally been active for Excellere. In August, the Firm sold Personable Insurance, a San-Diego-based provider of specialty auto insurance programs; and in November, PhyMed Healthcare Group, a Nashville, Tennessee based anesthesia and pain management provider, was sold to Ontario Teachers' Pension Plan.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Empowering Change: How Hologic is Shaping the Future of Women's Healthcare